BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23343909)

  • 21. Active Tuberculosis in HIV-Exposed Tanzanian Children up to 2 years of Age: Early-Life Nutrition, Multivitamin Supplementation and Other Potential Risk Factors.
    Olofin IO; Liu E; Manji KP; Danaei G; Duggan C; Aboud S; Spiegelman D; Fawzi WW
    J Trop Pediatr; 2016 Feb; 62(1):29-37. PubMed ID: 26494727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment.
    Yotebieng M; Van Rie A; Moultrie H; Cole SR; Adimora A; Behets F; Meyers T
    AIDS; 2010 Jun; 24(9):1341-9. PubMed ID: 20559039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
    Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
    Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.
    Edmonds A; Lusiama J; Napravnik S; Kitetele F; Van Rie A; Behets F
    Int J Epidemiol; 2009 Dec; 38(6):1612-21. PubMed ID: 19448046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
    Okechukwu AA; Okechukwu OI
    Niger J Clin Pract; 2011; 14(2):206-11. PubMed ID: 21860141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
    Anígilájé EA; Aderibigbe SA; Adeoti AO; Nweke NO
    PLoS One; 2016; 11(5):e0156177. PubMed ID: 27232185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
    Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
    BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Turkova A; Chappell E; Chalermpantmetagul S; Negra MD; Volokha A; Primak N; Solokha S; Rozenberg V; Kiselyova G; Yastrebova E; Miloenko M; Bashakatova N; Kanjanavanit S; Calvert J; Rojo P; Ansone S; Jourdain G; Malyuta R; Goodall R; Judd A; Thorne C
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1448-1456. PubMed ID: 27776584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.
    Miyano S; Muvuma S; Ishikawa N; Endo H; Msiska C; Syakantu G
    BMC Health Serv Res; 2013 Oct; 13():397. PubMed ID: 24103082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation and Operational Research: Risk Factors of Loss to Follow-up Among HIV-Positive Pediatric Patients in Dar es Salaam, Tanzania.
    McCormick NM; Li N; Sando D; Muya A; Manji KP; Kisenge R; Duggan C; Chalamilla G; Fawzi WW; Spiegelman D
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e73-83. PubMed ID: 26247894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
    Tiruneh F; Deyas Y
    Sci Rep; 2020 Dec; 10(1):21468. PubMed ID: 33293656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
    Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
    J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.
    Akanbi MO; Achenbach CJ; Feinglass J; Taiwo B; Onu A; Pho MT; Agbaji O; Kanki P; Murphy RL
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):931-7. PubMed ID: 23316724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional Status and Other Baseline Predictors of Mortality among HIV-Infected Children Initiating Antiretroviral Therapy in Tanzania.
    Mwiru RS; Spiegelman D; Duggan C; Seage GR; Semu H; Chalamilla G; Kisenge R; Fawzi WW
    J Int Assoc Provid AIDS Care; 2015; 14(2):172-9. PubMed ID: 24106055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
    Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
    BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.